|
Volumn 24, Issue 5, 2002, Pages 468-473
|
Prognostic factors in head and neck rhabdomyosarcoma
|
Author keywords
Age; Chemotherapy; Head and neck; Radiotherapy; Rhabdomyosarcoma; Surgery
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOXORUBICIN;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CHILD;
CONTROLLED STUDY;
DEMOGRAPHY;
FEMALE;
HEAD CANCER;
HISTOPATHOLOGY;
HUMAN;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
NECK CANCER;
PRIORITY JOURNAL;
PROGNOSIS;
RHABDOMYOSARCOMA;
TREATMENT OUTCOME;
TUMOR LOCALIZATION;
TUMOR VOLUME;
ADOLESCENT;
ADULT;
AGE FACTORS;
CHILD;
CHILD, PRESCHOOL;
COMBINED MODALITY THERAPY;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
INFANT;
MALE;
MIDDLE AGED;
PROGNOSIS;
REGISTRIES;
RETROSPECTIVE STUDIES;
RHABDOMYOSARCOMA;
SURVIVAL RATE;
|
EID: 0036250808
PISSN: 10433074
EISSN: None
Source Type: Journal
DOI: 10.1002/hed.10070 Document Type: Article |
Times cited : (59)
|
References (10)
|